Chorion Villus Biopsy Needle Set Market Report: Trends, Forecast and Competitive Analysis to 2031

The global chorion villus biopsy needle set market is expected to grow with a CAGR of 6.4% from 2025 to 2031. The major drivers for this market are the increasing preference for early detection and the rising availability of prenatal genetic testing.

The future of the global chorion villus biopsy needle set market looks promising with opportunities in the hospitals and clinics markets.

• The publisherl forecasts that, within the type category, diameter 17G is expected to witness higher growth over the forecast period.
• Within the application category, the hospitals are expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Chorion Villus Biopsy Needle Set Market

The chorion villus biopsy needle set market is evolving with several emerging trends that focus on improving patient experience, enhancing diagnostic accuracy, and making procedures more efficient. These trends are shaping the way chorion villus sampling is performed and expanding the market. Below are the key trends that are currently influencing this market.

• Miniaturization of Needle Sets: The trend towards smaller and more flexible needle sets is enhancing the precision and safety of chorion villus biopsy procedures. These advancements reduce the risk of complications such as miscarriage and improve patient comfort. Miniaturized needles are less invasive, allowing for more targeted procedures and reducing trauma to the uterine lining. This trend is widely welcomed by patients and healthcare providers alike, as it minimizes discomfort and improves the overall experience of prenatal testing.
• Integration of Ultrasound Guidance: Ultrasound guidance is becoming a standard practice for conducting chorion villus biopsy, ensuring better accuracy during the procedure. The integration of ultrasound technology enables real-time visualization of the fetus and the placenta, making it easier to guide the needle and avoid complications. This trend is gaining traction globally, as it significantly improves the success rate of CVS and reduces the likelihood of missteps during the procedure.
• Advancements in Biopsy Needle Coatings: New developments in biopsy needle coatings, such as hydrophilic or lubricating coatings, are reducing friction and making the insertion of the needle smoother. These coatings not only reduce the risk of tissue damage but also make the procedure less traumatic for the patient. Biopsy needles with coatings are being increasingly adopted in the market to enhance the overall procedure's safety and efficiency.
• Needle Set Customization: Customization of biopsy needles based on the specific requirements of patients is an emerging trend in the market. Factors such as needle length, diameter, and flexibility are being tailored to individual needs, improving the precision of the procedure and minimizing patient discomfort. Customization allows healthcare providers to adapt the tools to different patient body types, which is particularly important for achieving optimal results.
• Growing Use of Non-Invasive Prenatal Testing (NIPT): While not directly related to the needle set itself, the rise in non-invasive prenatal testing (NIPT) is influencing the chorion villus biopsy needle set market. As more patients opt for NIPT, there is a growing emphasis on performing CVS only when necessary, and advancements in CVS needle sets are focusing on improving outcomes for patients who still require the procedure. This shift in prenatal testing methods is pushing for the development of even more efficient and less invasive biopsy needle systems.

These emerging trends are reshaping the chorion villus biopsy needle set market by enhancing safety, comfort, and accuracy. As technologies like ultrasound guidance, miniaturization, and needle customization continue to evolve, the market will likely see further improvements in patient outcomes, ensuring the growth and development of this crucial diagnostic tool.

Recent Developments in the Chorion Villus Biopsy Needle Set Market

Recent developments in the chorion villus biopsy needle set market reflect the ongoing efforts to improve precision, reduce patient discomfort, and ensure better healthcare outcomes. These developments include technological advancements, the integration of new materials, and improvements in procedure guidance. Below are five key developments that have significantly impacted the market.

• Needle Set Design Enhancements: One of the most significant developments in the chorion villus biopsy needle set market has been the design improvements aimed at increasing precision and reducing discomfort. Innovations such as thinner, flexible needles have reduced the invasiveness of the procedure. The design of these needle sets ensures accurate placement with minimal tissue damage, ultimately improving patient satisfaction and reducing the risk of complications.
• Introduction of Ultrasound-Guided Biopsy Systems: Ultrasound guidance has become an essential tool in chorion villus biopsy, significantly improving the accuracy of needle placement. By allowing real-time imaging of the uterus and placenta, ultrasound guidance has decreased the risk of injury and miscarriage. This advancement has made the procedure safer and more effective, leading to its adoption in clinical settings worldwide.
• Adoption of New Biopsy Needle Materials: Recent advancements in the materials used to manufacture chorion villus biopsy needles have led to the development of more durable, flexible, and comfortable devices. These new materials enhance the overall procedure's success rate by ensuring smoother needle insertion and reducing friction. Additionally, the use of advanced materials has resulted in lighter, more precise needle sets that improve ease of use for healthcare providers.
• Growth of Robotic-Assisted Biopsy Systems: The use of robotic-assisted systems in chorion villus biopsy is an emerging development that improves the accuracy and reproducibility of the procedure. Robotic systems allow for more precise control of the biopsy needle, which reduces the potential for errors and improves patient outcomes. The adoption of robotic-assisted systems in major hospitals is growing, particularly in technologically advanced regions.
• Regulatory Approvals for New Devices: Regulatory bodies have recently approved new chorion villus biopsy needle sets, paving the way for advanced technologies to be used in clinical settings. These approvals are important as they ensure that new products meet safety standards while enhancing the overall quality of patient care. With more devices entering the market, competition is driving innovation, benefiting both healthcare providers and patients.

These developments are transforming the chorion villus biopsy needle set market by improving accuracy, safety, and patient comfort. The continued advancement in needle set designs, ultrasound-guided techniques, and robotic-assisted systems is positioning the market for future growth and providing better prenatal care solutions.

Strategic Growth Opportunities in the Chorion Villus Biopsy Needle Set Market

The chorion villus biopsy needle set market presents numerous growth opportunities across key applications, particularly as demand for prenatal testing and early genetic screenings increases globally. These opportunities range from technological advancements in needle designs to the adoption of new imaging techniques. Below are five strategic growth opportunities that are shaping the future of the market.

• Expansion of Ultrasound-Guided Biopsy Applications: As ultrasound technology improves and becomes more affordable, its integration with chorion villus biopsy procedures offers significant growth potential. Ultrasound guidance ensures greater precision and reduces complications, making the procedure safer and more effective. The widespread adoption of ultrasound guidance presents an opportunity for needle set manufacturers to develop more tailored products suited for ultrasound-guided procedures.
• Technological Advancements in Needle Customization: Customization of biopsy needles based on patient-specific needs is an emerging growth opportunity. As healthcare becomes more personalized, the demand for customized needle sets that cater to different body types, conditions, and gestational stages is expected to rise. Manufacturers can capitalize on this trend by developing customizable needle sets to meet diverse patient needs.
• Integration with Robotic Systems: The integration of chorion villus biopsy needle sets with robotic-assisted systems represents a significant growth opportunity. Robotic-assisted procedures offer enhanced precision and reproducibility, making them ideal for sensitive procedures like CVS. The adoption of robotics in clinical settings is expected to grow, providing a new market segment for needle set manufacturers to target.
• Increasing Demand in Emerging Markets: As awareness of prenatal genetic testing increases in emerging markets, the demand for advanced chorion villus biopsy needle sets is expected to rise. Countries with expanding healthcare infrastructure, such as India and China, present significant opportunities for market growth. Manufacturers can expand their reach in these regions by offering affordable, efficient, and easy-to-use needle sets.
• Development of Non-Invasive Alternatives: While non-invasive prenatal testing (NIPT) continues to grow, there will always be a need for CVS in certain cases. The development of more efficient, non-invasive alternatives to traditional methods could drive growth in the market by reducing the number of traditional biopsies required. Companies can invest in R&D to create products that work synergistically with new non-invasive technologies.

These growth opportunities highlight the ongoing transformation of the chorion villus biopsy needle set market. By leveraging advancements in technology, ultrasound guidance, and robotics, as well as capitalizing on emerging market demand, the market is poised for continued expansion and innovation.

Chorion Villus Biopsy Needle Set Market Driver and Challenges

The chorion villus biopsy needle set market is influenced by several major drivers and challenges. These include technological advancements, regulatory changes, market demand, and affordability. The interplay of these factors will significantly shape the future of the market. Below are the key drivers and challenges impacting the market.

The factors responsible for driving the chorion villus biopsy needle set market include:

• 1. Technological Advancements: Technological innovations in needle design, imaging techniques, and robotics are major drivers of the market. Advances such as miniaturized needles, ultrasound guidance, and robotic-assisted systems have improved the accuracy, safety, and comfort of CVS procedures, driving market growth.
• 2. Growing Awareness of Genetic Conditions: As awareness of genetic disorders and prenatal testing increases, more women are opting for early genetic screenings, driving the demand for chorion villus biopsy. The rising awareness of genetic conditions like Down syndrome and cystic fibrosis has led to an increase in prenatal diagnostic tests.
• 3. Increasing Adoption of Ultrasound Technology: The increasing adoption of ultrasound technology has contributed significantly to the chorion villus biopsy needle set market. Ultrasound provides real-time guidance during procedures, ensuring greater accuracy and reducing complications, which has helped improve the success rate of CVS.
• 4. Regulatory Support: Regulatory bodies have played a key role in ensuring the safety and efficacy of new biopsy needle devices. Regulatory approvals for advanced needle sets have paved the way for new technologies to enter the market, supporting its growth.
• 5. Improving Healthcare Access in Emerging Markets: With rising healthcare access and improving infrastructure in emerging markets, the demand for advanced prenatal diagnostic tools, including chorion villus biopsy needle sets, is increasing. This presents significant growth opportunities in regions like India, China, and Latin America.

Challenges in the chorion villus biopsy needle set market are:

• 1. Cost of Advanced Technologies: The high cost of advanced biopsy needle systems and imaging technologies remains a challenge, particularly in developing countries. Manufacturers need to address affordability concerns to ensure that these technologies are accessible to a broader patient base.
• 2. Limited Access in Rural Areas: Limited access to healthcare in rural and remote areas hampers the widespread adoption of advanced chorion villus biopsy needle sets. Ensuring that these technologies are accessible to patients in underserved areas will be a key challenge moving forward.
• 3. Training and Skill Gaps: There is a need for skilled practitioners who can perform CVS procedures accurately. Training healthcare professionals in advanced techniques and equipment is crucial to ensuring the effectiveness and safety of the procedures.

The chorion villus biopsy needle set market is growing due to technological advancements, increasing awareness of genetic conditions, and expanding healthcare access. However, challenges such as high costs, limited access in rural areas, and the need for skilled professionals need to be addressed for sustainable market growth.

List of Chorion Villus Biopsy Needle Set Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chorion villus biopsy needle set companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chorion villus biopsy needle set companies profiled in this report include:

• Cook Medical
• Sterylab
• Biopsybell
• Rocket Medical
• Smiths Medical

Chorion Villus Biopsy Needle Set Market by Segment

The study includes a forecast for the global chorion villus biopsy needle set market by type, application, and region.

Chorion Villus Biopsy Needle Set Market by Type [Value from 2019 to 2031]:

• Diameter 17G
• Diameter 18G
• Others

Chorion Villus Biopsy Needle Set Market by Application [Value from 2019 to 2031]:

• Hospitals
• Clinics
• Others

Chorion Villus Biopsy Needle Set Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Chorion Villus Biopsy Needle Set Market

The chorion villus biopsy needle set market has seen significant developments in recent years due to advancements in medical technology, growing awareness of genetic conditions, and increasing demand for early prenatal diagnostic procedures. Chorion villus sampling (CVS) is a crucial diagnostic technique for detecting genetic disorders in the early stages of pregnancy, and improvements in needle sets have enhanced its accuracy and patient comfort. Key regions like the United States, China, Germany, India, and Japan have experienced unique developments that reflect both global trends and regional healthcare advancements. Below is a summary of recent developments in the market across these countries.

• United States: In the United States, there has been a significant push toward improving the precision and safety of chorion villus biopsy needle sets. Innovations include the development of smaller, more flexible needle sets that reduce the risk of miscarriage and other complications. Advances in imaging technologies such as ultrasound guidance have also improved the accuracy of the procedure. The FDA's regulatory approvals of new devices have further fueled the growth of this market, along with an increased emphasis on genetic screening as part of standard prenatal care.
• China: China's healthcare market for chorion villus biopsy needle sets is growing rapidly due to rising awareness of genetic disorders and rising demand for prenatal testing. Newer needle sets, designed to minimize discomfort and risk, are being introduced. Chinese healthcare providers are also integrating advanced ultrasound systems to assist with needle placement, which improves the success rate of CVS procedures. However, despite advancements, the market faces challenges related to affordability and access to the latest technologies in rural areas.
• Germany: Germany continues to be a leader in Europe for medical device innovation, with significant advancements in the chorion villus biopsy needle set market. The focus is on creating needle sets that are more precise, with innovations such as needles with coatings to reduce friction and minimize tissue damage. Germany also benefits from a robust healthcare infrastructure that allows for the widespread use of advanced techniques like ultrasound-guided CVS. Research in the country continues to support the development of next-generation diagnostic tools, contributing to the market's growth.
• India: India is witnessing a rapid rise in demand for prenatal testing, driven by increasing awareness of genetic conditions and the availability of advanced diagnostic technologies. The chorion villus biopsy needle set market is expanding as healthcare providers in both urban and rural regions adopt more efficient and less invasive tools. While there is a growing demand for CVS, challenges like affordability, lack of access to the latest technologies in rural areas, and the need for skilled practitioners remain.
• Japan: Japan has seen substantial growth in the chorion villus biopsy needle set market, driven by the aging population and a strong emphasis on early genetic testing. The market is witnessing the development of smaller, more flexible needle sets that reduce the discomfort associated with CVS procedures. Japan is also integrating cutting-edge imaging technologies to enhance the precision and effectiveness of CVS. Additionally, Japan's healthcare system ensures widespread access to prenatal genetic testing, further promoting the market's growth.

Features of the Global Chorion Villus Biopsy Needle Set Market

• Market Size Estimates: Chorion villus biopsy needle set market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Chorion villus biopsy needle set market size by type, application, and region in terms of value ($B).
• Regional Analysis: Chorion villus biopsy needle set market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the chorion villus biopsy needle set market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chorion villus biopsy needle set market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the chorion villus biopsy needle set market by type (diameter 17G, diameter 18G, and others), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?